4//SEC Filing
Lager Joanne Jenkins 4
Accession 0001209191-22-009568
CIK 0001808865other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:59 PM ET
Size
11.5 KB
Accession
0001209191-22-009568
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-11$35.52/sh−1,982$70,401→ 1,518 total - Sale
Common Stock
2022-02-11$36.27/sh−1,518$55,058→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2022-02-11−3,500→ 182,438 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2022-02-11$4.30/sh+3,500$15,050→ 3,500 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.9 to $35.875, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.935 to $36.555, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816215
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 7:59 PM ET
- Size
- 11.5 KB